HomeCompareSYK vs ANSS

SYK vs ANSS: Dividend Comparison 2026

SYK yields 1.04% · ANSS yields 0.53%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $22.9K in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
ANSS
ANSS
● Live price
0.53%
Share price
$374.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.4K
Annual income
$55.32
Full ANSS calculator →

Portfolio growth — SYK vs ANSS

📍 SYK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKANSS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + ANSS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
ANSS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
ANSS
Annual income on $10K today (after 15% tax)
$45.42/yr
After 10yr DRIP, annual income (after tax)
$47.02/yr
At 15% tax rate, SYK beats the other by $6,993.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + ANSS for your $10,000?

SYK: 50%ANSS: 50%
100% ANSS50/50100% SYK
Portfolio after 10yr
$31.9K
Annual income
$4,169.15/yr
Blended yield
13.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
ANSS
Analyst Ratings
10
Buy
15
Hold
3
Sell
Consensus: Hold
Price Target
$363.20
-3.0% upside vs current
Range: $315.00 — $425.00
Altman Z
12.9
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
ANSS buys
0
No recent congressional trades found for SYK or ANSS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKANSS
Forward yield1.04%0.53%
Annual dividend / share$3.40$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%0%
Portfolio after 10y$43.3K$20.4K
Annual income after 10y$8,282.98$55.32
Total dividends collected$21.0K$545.00
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyHold
Analyst price target$428.67$363.20

Year-by-year: SYK vs ANSS ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrANSS PortfolioANSS Income/yrGap
1← crossover$10,852$152.43$10,753$53.43+$99.00SYK
2$11,838$226.03$11,560$53.70+$278.00SYK
3$13,004$336.89$12,423$53.95+$581.00SYK
4$14,420$505.63$13,347$54.19+$1.1KSYK
5$16,195$766.09$14,335$54.41+$1.9KSYK
6$18,504$1,175.64$15,394$54.61+$3.1KSYK
7$21,635$1,835.40$16,526$54.81+$5.1KSYK
8$26,082$2,932.10$17,738$54.99+$8.3KSYK
9$32,737$4,829.68$19,035$55.16+$13.7KSYK
10$43,312$8,282.98$20,422$55.32+$22.9KSYK

SYK vs ANSS: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

ANSSTechnology

ANSYS, Inc. develops and markets engineering simulation software and services worldwide. It offers ANSYS Workbench, a framework upon which its multiphysics engineering simulation technologies are built and enables engineers to simulate the interactions between structures, heat transfer, fluids, electronics, and optical elements in a unified engineering simulation environment; high-performance computing product suite; power analysis and optimization software suite that manages the power budget, power delivery integrity, and power-induced noise in an electronic design; and structural analysis product suite that provides simulation tools for product design and optimization. The company also provides electronics product suite that offers field simulation software for designing electronic and electromechanical products; SCADE product suite, a solution for embedded software simulation, code production, and automated certification; fluids product suite that enables modeling of fluid flow and other related physical phenomena; Ansys Granta products to give access to material intelligence; photonic design and simulation tools; and optical sensor and closed-loop, and real-time simulation, as well as safety-certified embedded software solutions. In addition, the company provides Discovery product family for use in the simulation of product design; and academic product suite used in research and teaching settings, which allows students to become familiar with its simulation software. It serves engineers, designers, researchers, and students in the aerospace and defense, automotive transportation and mobility, construction, consumer products, energy, healthcare, high-tech, industrial equipment, materials and chemical processing, and sports industries. The company was founded in 1970 and is headquartered in Canonsburg, Pennsylvania.

Full ANSS Calculator →
📬

Get this SYK vs ANSS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.